301520 萬邦醫藥
按盤價 
28.260 +4.710 (+20.000%)
28.260 +4.710 (+20.000%) | 2026/03 - 三個月 | 2025/12 | 2024/12 | 2023/12 | 2022/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | -0.017 | 2.406 | 5.745 | 12.039 | 34.981 |
| 總資產報酬率 ROA (%) | -0.016 | 2.273 | 5.433 | 11.091 | 28.692 |
| 投入資產回報率 ROIC (%) | -0.017 | 2.360 | 5.640 | 11.712 | 32.523 | 邊際利潤分析 |
| 銷售毛利率 (%) | 15.245 | 25.899 | 39.579 | 48.938 | 50.382 |
| 營業利潤率 (%) | -5.908 | 15.123 | 22.960 | 34.817 | 40.679 |
| 息稅前利潤/營業總收入 (%) | -6.266 | 12.712 | 22.778 | 33.654 | 42.280 |
| 淨利潤/營業總收入 (%) | -0.857 | 13.289 | 22.562 | 31.624 | 37.861 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 559.288 | 25.206 | 66.123 | 92.770 | 88.699 |
| 價值變動淨收益/利潤總額(%) | -396.568 | 89.023 | 31.498 | 5.198 | 2.857 |
| 營業外收支淨額/利潤總額(%) | 0.000 | -15.654 | 2.745 | 0.534 | 4.555 | 償債能力分析 |
| 流動比率 (X) | 20.601 | 20.785 | 18.774 | 20.351 | 4.387 |
| 速動比率 (X) | 20.581 | 20.772 | 18.748 | 20.341 | 4.380 |
| 資產負債率 (%) | 5.327 | 5.437 | 5.639 | 5.217 | 18.038 |
| 帶息債務/全部投入資本 (%) | 1.169 | 0.594 | 0.797 | 0.946 | 4.158 |
| 股東權益/帶息債務 (%) | 8,346.567 | 16,504.503 | 12,317.597 | 10,378.571 | 2,252.206 |
| 股東權益/負債合計 (%) | 1,777.303 | 1,739.230 | 1,673.349 | 1,816.848 | 454.373 |
| 利息保障倍數 (X) | 17.483 | -34.845 | -27.427 | -24.926 | -123.982 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 222.645 | 95.335 | 55.514 | 45.530 | 33.319 |
| 存貨周轉天數 (天) | 3.813 | 2.509 | 2.064 | 1.145 | 0.868 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 29/06/2026 16:30 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
